GlassScriptPhysician profile
Martin W Lapa
NPI 1639184070
$2,894.79
in general payments reported to CMS, 2019-2025
24 companies · $470 in 2025
The $470 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.65 · 2020: $81.19 · 2021: $300 · 2022: $699 · 2023: $812 · 2024: $436 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.72 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $570.96 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $384.60 | 2023-2024 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $366.17 | 2019-2025 | Aptima, Coolseal Generator, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $289.45 | 2022 | |
| Organon LLC | $230.49 | 2023-2025 | Nexplanon |
| Pfizer INC. | $163.78 | 2019-2024 | |
| Astellas Pharma US INC | $128.39 | 2021-2025 | Veozah |
| Mayne Pharma Commercial LLC | $119.87 | 2023-2025 | |
| Philips North America LLC | $119.27 | 2024 | (Bh4) Igt Devices Undivided |
| Coloplast Corp | $97.74 | 2023-2025 | Altis |
| Channel Medsystems, INC. | $60.95 | 2025 | |
| Aspira Women'S Health INC | $51.95 | 2022 | |
| Coopersurgical, INC. | $49.31 | 2022-2025 | Paragard T 380a |
| Exeltis, USA INC. | $45.77 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $43.96 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $32.81 | 2021 | |
| Lsi Solutions INC | $22.99 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.05 | 2021 | |
| Millicent US INC | $19.68 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $19.07 | 2025 | |
| Minerva Surgical, INC | $17.60 | 2022 | |
| Medtronic, INC. | $15.53 | 2021 | |
| Covidien LP | $13.41 | 2019 | |
| Allergan, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Lapa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.